Clinical Trial Update: Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a CpG-activated whole cell vaccine followed by autologous immunotransplant in mantle cell lymphoma; trial completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• CpG-activated whole cell vaccine

Snippet

Sponsor: Ronald Levy | Conditions: Lymphoma, Mantle-Cell | Phase 2 | Status: COMPLETED | Results posted: 2020-01-13